Piramal Pharma turns to biomass

Piramal Pharma has converted its coal-fired steam boiler to a biomass-fuelled one at its manufacturing facility in Digwal, India.
The strategic conversion at the Digwal facility will eliminate approximately 24,000 tonnes of carbon dioxide equivalent (tCO2e) GHG emissions annually, accounting for about 17% of the company's total emissions, said the company.
Adopting biomass briquettes is a key advancement in Piramal's sustainability journey. These briquettes are compacted blocks of biomass materials processed and compressed under high pressure. Biomass briquettes, made from agricultural waste, are a renewable fuel source that supports circular economy principles by recycling organic by-products, reducing waste, and promoting sustainability.
"The transition to biomass briquettes at our Digwal facility is a testament to our commitment to reducing our environmental footprint while driving innovation in sustainable manufacturing. As we align our goals with global climate action frameworks, we will continue to contribute to a more sustainable future for generations to come," said Nandini Piramal, chairperson, Piramal Pharma Limited.
"This transformation at our Digwal facility underscores our commitment to environmental stewardship and sustainable operational practices," said Peter DeYoung, CEO of Piramal Global Pharma. "By transitioning to biomass briquettes, we are significantly reducing our GHG emissions and setting new industry standards for responsible pharmaceutical manufacturing."